PDCD1 and neoplasm: PD-1 expression by NK cells is also frequently observed in the context of cancers in which the PD-1 ligands PD-L1/L2 are highly expressed by tumor cells [48,49], which is frequently the case for EBV-positive PTLDs [50,51].